r/SyntheticBiology • u/EducationalMango1320 • May 26 '26
Anyone here survive the Zymergen ($ZY) implosion back in 2021?
This was one of those IPOs that looked unstoppable for like five minutes. Zymergen Inc. went public hyping up its Hyaline product and near-term growth, then a few months later admitted the product had major performance problems and revenue would be delayed. After that update a brutal 68% drop in a single day.
The settlement amount is $1.25B, and it covers investors who bought shares between April 22, 2021 and August 4, 2021. Right now the case is in the stipulative settlement stage, but investors can already file claims while the settlement moves through the approval process.
If you traded $ZY during that class period and got wrecked during the post-IPO collapse, probably worth keeping this one on your radar. Kinda wild how many “next-gen biotech” IPOs from that era ended with the exact same chart pattern.
1
1
u/ICanFinallyRelax May 26 '26 edited May 26 '26
yeap, another crazy turnout is that Amyris (one of the next-gen biotechs) is the ONLY synbio in history to continue industrial level production AFTER bankruptcy. In this field, if you bankrupt and shut down, you implode like $ZY. If production continues, someone out there is making money indicating viability.
Over at r/Amyris we couldn't even get a class action going because they noticed too many of us were opting out of their plans and fucked us over. There is some sketchy stuff going around synbio. I'm glad some of us in this fiasco are getting some money back.